Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhong-Min Liu
The ODYSSEY DM-DYSLIPIDEMIA Trial: Confirming the Benefits of Alirocumab in Diabetic Mixed Dyslipidemia
Annals of Translational Medicine
Medicine
Related publications
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial†
Journal of Clinical Lipidology
Internal Medicine
Nutrition
Cardiology
Endocrinology
Cardiovascular Medicine
Dietetics
Metabolism
Diabetes
The Effect of Aggressive Versus Standard Lipid Lowering by Atorvastatin on Diabetic Dyslipidemia: The DALI Study: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Type 2 Diabetes and Diabetic Dyslipidemia
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Dyslipidemia Guidelines
CMAJ
Medicine
The Role of Niacin in the Management of Dyslipidemia†
Journal of Clinical Lipidology
Internal Medicine
Nutrition
Cardiology
Endocrinology
Cardiovascular Medicine
Dietetics
Metabolism
Diabetes
Administration of CORM-2 Inhibits Diabetic Neuropathy but Does Not Reduce Dyslipidemia in Diabetic Mice
PLoS ONE
Multidisciplinary
Methylphenidate and Dyslipidemia
Nutrigenetics and Dyslipidemia
6. Update for the Management of Dyslipidemia
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
Atorvastatin Versus Rosuvastatin in Non-Diabetic Patients With Dyslipidemia: A Comparative Study
International Journal of Basic and Clinical Pharmacology
